<p> Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it matters, especially as COVID-19 variants begin to spread, with Tom Frieden, former head of the CDC.</p>

Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it matters, especially as COVID-19 variants begin to spread, with Tom Frieden, former head of the CDC.

<p>&nbsp;Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson &amp; Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it matters, especially as COVID-19 variants begin to spread, with Tom Frieden, former head of the CDC.</p>

Ex-CDC director Tom Frieden on the next COVID-19 vaccines

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app. 

Axios Re:Cap is on hiatus until October 2021.

News

Daily News

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app. Axios Re:Cap is on hiatus until October 2021.

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app.&nbsp;

Axios Re:Cap is on hiatus until October 2021.

Share Ex-CDC director Tom Frieden on the next COVID-19 vaccines

Sign up to save your podcasts

Ex-CDC director Tom Frieden on the next COVID-19 vaccines

Ex-CDC director Tom Frieden on the next COVID-19 vaccines

More shows like Axios Re:Cap

WSJ Tech News Briefing

WSJ What’s News

WSJ Your Money Briefing

Marketplace

Fareed Zakaria GPS

The Daily

Up First from NPR

Radio Atlantic

Post Reports

The Journal.

Morning Brew Daily

1 big thing

The Ezra Klein Show

How It Happened

The Big Take

The 7

The Opinions